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Abstract
Hox  genes are an evolutionary highly conserved gene 
family. They determine the anterior-posterior body axis 
in bilateral organisms and influence the developmental 
fate of cells. Embryonic stem cells are usually devoid 
of any Hox  gene expression, but these transcription 
factors are activated in varying spatial and temporal 
patterns defining the development of various body 
regions. In the adult body, Hox  genes are among others 
responsible for driving the differentiation of tissue 
stem cells towards their respective lineages in order to 
repair and maintain the correct function of tissues and 
organs. Due to their involvement in the embryonic and 
adult body, they have been suggested to be useable for 
improving stem cell differentiations in vitro  and in vivo . 
In many studies Hox  genes have been found as driving 
factors in stem cell differentiation towards adipogenesis, 
in lineages involved in bone and joint formation, mainly 
chondrogenesis and osteogenesis, in cardiovascular 
lineages including endothelial and smooth muscle cell 
differentiations, and in neurogenesis. As life expectancy 
is rising, the demand for tissue reconstruction continues 
to increase. Stem cells have become an increasingly 
popular choice for creating therapies in regenerative 
medicine due to their self-renewal and differentiation 
potential. Especially mesenchymal stem cells are used 
more and more frequently due to their easy handling 
and accessibility, combined with a low tumorgenicity 
and little ethical concerns. This review therefore intends 
to summarize to date known correlations between 
natural Hox  gene expression patterns in body tissues 
and during the differentiation of various stem cells 
towards their respective lineages with a major focus on 
mesenchymal stem cell differentiations. This overview 
shall help to understand the complex interactions of Hox  
genes and differentiation processes all over the body 
as well as in vitro  for further improvement of stem cell 
treatments in future regenerative medicine approaches.
Key words: Genes; Homeobox; Stem cells; Asymmetric 
cell division; Mesenchymal stromal cells; Growth; 
Development; Regeneration; Patterning; Cell lineage
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Hox genes are involved in embryonic development 
as well as in repair mechanisms in the adult body, thus 
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regulating cell fate. These genes have also been found to be 
driving factors in various stem cell differentiations in vitro  
and in vivo  which makes them interesting tools for future 
improvements in stem cell therapies. Therefore, this review 
outlines the involvement of Hox genes in various stem cell 
differentiations with a major emphasis on mesenchymal 
stem cell differentiations.
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INTRODUCTION
The life expectancy of the overall population has 
increased in most countries, accompanied by an increase 
in injuries, diseases, and age related degenerative 
diseases. Thus, reconstructions of hard and soft tissues 
are an increasing challenge in regenerative medicine[1]. 
Stem cells could help to overcome these restrictions 
using their self-renewal and differentiation properties, 
with or without biomaterials or artificial scaffolds[1-3]. 
Numerous sources are known from which stem cells 
can be isolated, often with a varying differentiation 
potential[4]. Additionally, the commitment might depend on 
the body site from which the stem cells were isolated[4,5]. 
In vivo, stem cell fate is determined according to tissues 
and thus extracellular but also intracellular factors, 
among them p53, purinergic receptors, collagens, 
parathyroid hormone-related proteins, or homeobox 
(Hox) genes[6-9]. The later are the central players in 
determining regional specificity in the developing 
embryo and not astonishingly also in numerous 
differentiations[10].
The Hox gene family consists of 39 members, 
which are clustered in four paralogous groups and 
are numbered from 1-13 within the groups. During 
embryogenesis, Hox genes show an expression pattern 
which is specific for each body region, commonly 
referred to as the HOX code. They are an evolutionary 
highly conserved collection of genes binding to various 
DNA recognition sites and thus influencing a cell’s 
developmental fate in a huge variety of species, while 
determining the anterior-posterior body axis[11] (Figure 
1). The precise function of these genes is achieved by 
their specific temporal and spatial activation over the 
course of life. Due to this role in embryonic and adult 
developmental stages, Hox genes are expected to also 
have fundamental influences on the differentiation of 
various stem cells in vivo and in vitro towards their 
respective lineages. There have been studies which 
directly identified Hox gene involvement in stem cell 
differentiations, and others which suggest their role 
based on observed effects of Hox genes in in vivo or in 
vitro tissue development. It has been speculated that 
the code may contribute to maintaining the stem cell 
character in certain niches, since it is also regulated on 
an epigenetic level[12].
This review will outline the Hox profile of various 
stem cells, and discuss the wide range of findings 
concerning Hox genes in stem cell differentiations 
gathered over the last decade. The nomenclature 
used for Hox genes in this study is according to the 
current regulations, meaning that Hox genes related to 
findings in mice and rats are written with the first letter 
capitalized, whereas the following are in small capitals 
(e.g., Hoxc8). For findings in human and chicken, all 
letters are capitalized (e.g., HOXC8). Understanding the 
principle behind the role of Hox genes in differentiations 
and development may provide improved possibilities 
to alter stem cell fate in vitro and in vivo, and therefore 
might result in new or improved approaches in reg-
enerative medicine.
Therapeutic approaches are more and more based 
on the use of mesenchymal stem cells (MSCs), due to 
their easy accessibility and handling compared to other 
kinds of stem cells. Hence, we put specific emphasis 
on the differentiation lineages of MSCs within this 
review.
HOX TRANSCRIPTION FACTORS IN 
STEM CELLS
Embryonic stem cells
Embryonic stem cells (ESCs) can be gained from the 
inner cell mass of the blastocyst and are therefore 
derived from an early stage embryo[13,14]. They are 
characterized by various markers, having the most 
significant surface markers SSEA-1, SSEA-3, SSEA-4 
as well as TRA-1-60 and TRA-1-81[15]. Additionally 
ESCs are positive for the transcription factors NANOG 
and OCT3/4[16,17]. Their pluripotency, the potential to 
differentiate into each cell lineage and all types of cells 
of the body, and the proliferation rate causes huge 
interest in this stem cell type[18,19]. An active repression 
of Hox clusters has been demonstrated in various 
studies. On the other hand Hox genes are activated 
when differentiation processes take place[20]. However, 
it is not known which Hox code exactly commits these 
cells into the different lineages, yet[20].
Hematopoietic stem cells
Hematopoietic stem cells (HSCs) are the best chara-
cterized type of adult stem cells[21]. They can be obtained 
from bone marrow, cytokine-mobilized peripheral blood, 
and cord blood[22]. HSCs are characterized with the 
antigen cell-surface markers CD34, C-KIT, TIE, and 
CD133/AC133 and they lack CD38, LIN, and CD45RA[23]. 
These stem cells differentiate into all kinds of blood 
cell lineages serving the reconstruction of the lympho-
hematopoietic system[24]. In general, the HOXA cluster 
plays a role in hematopoiesis[25], but the expression of 
HOXB4 which directs transition from the embryonic to 
the adult hematopoietic program is a major factor as 
584 April 26, 2015|Volume 7|Issue 3|WJSC|www.wjgnet.com
well[21].
Neural crest cells
Neural crest cells (NCCs) are multipotent cells exclusively 
present in vertebrates[26]. These cells are not only 
found in the early embryonic development but are 
also present in various neural crest-derived tissues in 
the fetal and adult organism[27]. NCCs are located in 
between the neural epithelium and epidermis in the 
neurulating vertebrate embryo[26]. After they have 
undergone epithelial-mesenchymal transition the NCCs 
migrate within the embryonic tissue to the respective 
location and undergo differentiation[28]. This stem 
cell type commits towards facial cartilage, bone and 
connective tissue as well as neural and glial cells of the 
peripheral nervous system. Additionally, they are able to 
differentiate into skin pigment cells, mesenchyme and 
in restricted locations into smooth muscle cells[29]. NCCs 
are characterized with the markers p75NTR, AP-2α 
and the transcription factors MSX1, MSCX2 and SLUG 
in the pre-migratory state[30]. In post-migratory state, 
embryonic and adult cell markers can be distinguished 
as follows: in the embryo, adult gut and bone marrow 
p75 is present, whereas SOX10 is found in the dorsal 
root ganglia of the embryo and in the adult bone 
marrow. As an additional marker NESTIN is suggested 
because it is present in the adult heart and embryonic 
boundary cap cells. Other markers are MUSASHI in 
the adult heart, SCA1 and CD34 in the adult cornea as 
well as SLUG and SNAIL in the adult bone marrow[26]. 
Usually there are no Hox genes expressed in NCCs[31]. 
However data has been found where Hoxa2 and Hoxd9 
can be induced in mouse trunk neural crest cells by 
retinoic acid, a major factor triggering differentiation[32]. 
Additionally, Hoxd3 has been shown to have an impact 
on the formation of somitic mesoderm-and neural crest-
derived structures during mouse development[33].
MSCs
MSCs are multipotent adult stem cells which can be in 
vitro differentiated towards lineages of mesenchymal 
tissues[7,34,35], which is in line with their natural repair 
function in the body where they regenerate mesenchymal 
tissues like bone, cartilage, muscle ligament, tendon and 
adipose tissues[7,36]. In addition it has been described that 
these stem cells can also differentiate towards lineages of 
the other two germ layers, such as towards endothelial 
cells, hepatocytes[37], or neurons of the ectoderm[38]. 
MSCs are found in the stroma of various tissues or organs 
such as bone marrow, umbilical cord, wisdom teeth and 
adipose tissues[5,7,39]. Defined characteristics of these 
stem cells are the plastic adherence under standard 
culture conditions, the presence of the antigen surface 
markers CD73, CD90 and 105 and the absence of CD34, 
CD45, CD14 or CD11b, CD79α or CD19 and HLA-DR[40]. 
Since Hox genes are involved in organ formation and 
regeneration, it is not astonishing that the degree of Hox 
gene expression in various adult stem cell populations 
differs which enables the discrimination of adult stem 
cells by the respective Hox expression pattern. Cord 
blood-derived MSCs (CB-MSCs) and unrestricted somatic 
stem cells (USSCs) are gained from cord blood. Whereas 
CB-MSCs are positive for HOXA9, HOXB7, HOXC10 and 
HOXD6, USSCs resembling the profile of typical ESCs 
are negative for Hox genes. In CB-MSCs and USSCs 
it has been demonstrated that this expression code is 
in line with the differentiation potential of stem cells: 
CB-MSCs can be differentiated towards the adipogenic 
lineage whereas USSCs generally can be committed 
towards all three germ layers and show nevertheless 
no adipogenic differentiation. HOXB7 and HOXD6 
expression has also been shown in bone marrow-derived 
MSCs that generally have a similar expression profile as 
MSCs derived from adipose tissue. Amnion- and decidua-
derived MSCs can be distinguished using HOXC10 
expression[41]. Taken together, a distinct expression of 
HOXA5 and A10, HOXB6, B7, HOXC4, C6, C8, C9 and 
C10 as well as HOXD3 and D8 is observed in MSCs 
derived from different human sources[42]. In murine 
MSCs the expression of Hoxb2, b5, b7 and Hoxc4 has 
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Figure 1  Roles of Hox genes in the organisms and the cell[135-140].
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show an overexpression of HOXA4 and HOXD10 which 
distinguishes colonic stem cells from colon carcinoma 
cells[51]. 
Induced pluripotent stem cells
Induced pluripotent stem cells (iPS) have similar 
characteristics as ESCs including pluripotency and 
immortality[52]. As can be seen in Table 1, both stem cell 
types are generally negative for Hox gene expression. 
iPS cells are generated by introducing four defined 
transcription factors into somatic cells, which are OCT3/4, 
SOX2, KLF4, c-Myc or NANOG, and Lim2b replacing the 
later two[53,54]. In the meantime, several somatic cells 
can be reprogrammed such as fibroblasts, hepatocytes, 
keratinocytes and circulating T-cells, also with a reduced 
set of transcription factors, ranging from four factors 
to one factor with respect of the target cell[55]. Both, 
ESCs and iPS cells are characterized by the pluripotency 
markers NANOG, OCT3/4, ERAS, ESG1 and ECAT as 
well as TRA-1-60[53,56]. As iPS cells can differentiate into 
the same lineages as ESCs, which is the differentiation 
into all cell types of the three germ layers[57], the Hox 
gene expression is similar as well. It is repressed as they 
are quiescent and up-regulated when the differentiation 
processes start[58].
HOX TRANSCRIPTION FACTORS IN 
VARIOUS DIFFERENTIATIONS
Hox expression in adipogenic differentiation
The understanding of adipose tissue as an organ with 
a detrimental effect on the whole organism, due to its 
secreted adipokines, led to increased studies during 
the last decades, since the number of obesity patients 
rises all over the world. A dysfunction of adipocytes in 
obese patients can, e.g., lead to diabetes type Ⅱ and 
cardiovascular diseases[59], the leading cause of death 
in industrialized countries. Thus understanding the 
been shown, which regulate self-renewal and influence 
the differentiation of other stem cells[43].
Cancer stem cells
Cancer stem cells (CSCs) are cancer cells with the 
capability of both, self-renewal and differentiation, 
which are the typical characteristics of any stem cell[44]. 
These stem cells are multipotent, clonogenic, have 
the capability to induce new tumors and eventually 
create heterogeneous cell lineages in tumors[45]. 
Accordingly they are thought to be responsible for 
progression of cancer, cancer metastasis, and therapy 
resistance of cancers[46]. In addition, the recurrence and 
spreading of cancer might be due to CSCs that remain 
in residual tumors after surgery and treatment. It 
was suggested that a tumor contains different stem 
cell like populations due to reduced cell differentiation 
within a tumor and this heterogeneous population 
also includes CSCs[44,45]. DNA damages may render 
tissue stem cells to become CSCs on their way from a 
stem cell to a fully differentiated cell. However, instead 
of dying at the different levels of differentiation like 
normal tissue stem cells do these cancer precursors 
do not differentiate normally but accumulate forming 
tumors[47]. Conclusively, this population differs in marker 
expression and growth capacities[45]. In general CSCs 
can be characterized by the presence of the markers 
CD24, CD29, CD44, CD90, CD133 and CD166[44,45]. 
In some cancers it has been observed that Hox genes 
are upregulated which are normally restricted to 
undifferentiated or proliferative cells, and vice versa a 
down-regulation has been shown of those Hox genes 
which are normally present in fully differentiated 
cells[48]. For instance, HOXA9 seems to play a role in 
acute myelogenous leukemia[49]. HOXB7, HOXC6 and 
C9 transcription factors function in intima formation and 
vascularization in vascular-wall multipotent stem cells, 
which is in line with vascularization being important 
for cancer metastasis[50]. Further, colon carcinomas 
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Table 1  Hox  gene expression in various kinds of stem cells
Type of stem cell Hox  expression Role of Hox
HSC HOXA cluster Hematopoiesis and its transition from embryonic to adult program 
HOXB4
MSC HOXA5, 10 Degree of Hox expression pattern differs in the different sources and determines differentiation potential
HOXB6, 7
HOXC4, 6, 8, 9, 10
HOXD3 and D8
ESC None Active repression of Hox genes until commitment starts
CSC Various Overexpression of Hox genes present in undifferentiated cells and down-regulation Hox genes present in 
differentiated cells 
HOXA9 Hematopoiesis 
HOXB7, C6, C8 Vascularization 
HOXA4, D10 Colon carcinoma 
NCC HOXD3 Formation of somitic mesoderm- and neural crest-derived structures 
iPS None Active repression of Hox genes until commitment starts
HSC: Hematopoietic stem cells; MSC: Mesenchymal stem cells; ESC: Embryonic stem cells; CSC: Cancer stem cells; NCC: Neural crest cells; iPS: Induced 
pluripotent stem cells.
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molecular mechanisms in adipogenesis has therefore 
gained much importance. 
Hox gene expression in developing adipocytes has 
been studied in the pre-adipogenic committed murine 
cell line 3T3-L1, where Hoxa4, a7, and Hoxd4 are 
involved in the differentiation towards adipocytes[60]. 
In human adipose tissue-derived stem cells (hAT-SC), 
HOXC8 expression is drastically down-regulated during 
adipogenesis and almost vanishes in mature adipocytes. 
However, the down-regulation does not arise from a 
change of RNA expression, but is rather due to post-
translational modifications by miRNAs. Forced expression 
of HOXC8 in hAT-SC inhibits adipogenesis to a certain 
extent, indicating that this Hox gene has a functional 
role during the differentiation of these stem cells towards 
adipocytes[61].
There is also evidence that HOXA1, A4 and HOXC4 
are directly involved in the differentiation and further 
generation of human white and brown adipose tissue[62]. 
Additionally, the Hox gene expression pattern is varying 
in adipocytes derived from different fat deposits within 
the human body. This pattern is also reflected in the in 
vitro differentiation of human primary pre-adipocytes 
isolated from the respective region. For instance pre-
adipocytes isolated from the abdominal fat depot show 
an increased expression of HOXA5 and HOXB8 during 
differentiation towards adipocytes, as compared to 
gluteal pre-adipocytes, where HOXA10 expression is 
higher, and HOXC13 expression is exclusively restricted 
to gluteal pre-adipocytes[63]. Due to this variation in the 
expression pattern, a general statement about the Hox 
gene expression in differentiating adipocytes would not 
be sensible. 
Understanding the principles of Hox signaling in 
white and brown adipose tissue formation might help 
prevent health damage in obese patients, such as the 
development of diabetes and consecutive the metabolic 
syndrome.
Hox expression in chondro-osteogenesis
Understanding the development of joints and bones 
is of interest in many fields of research, including 
regenerative medicine. However, the complete formation 
of limbs and other hard tissues involves various 
types of cells and a complex interplay between them. 
Three main tissue types can be attributed to bone and 
joint formation, namely tendons, cartilage and bone. 
Chondral tissue is the first to develop in limb formation, 
and its condensation is needed for correct bone 
development. Of great importance in tissue engineering 
are the underlying signaling pathways and proteins 
involved[64]. By investigating the Hox gene expression in 
chondrocytes and osteoblasts, both, in vitro and in vivo, 
bone formation and regeneration might be improved 
in the future, since in both cell types Hoxa2 and Hoxd9 
have been shown to be significantly regulated. Hoxa2 
is up-regulated in bone regeneration of rats after post-
fracture day 10, whereas Hoxd9 is down-regulated 
after this time period[65]. In mice, Hoxa2 impairs 
chondrogenesis in the mesenchymal-to-chondrocyte 
differentiation step leading to a proportionate short 
stature. Additionally, in a Hoxa2 gain-of-function 
mice model molecular regulators for an endochondral 
ossification are decreased[66]. In normal mouse 
development, Hoxa2 inhibits chondrogenesis and 
intramembranous ossification as well as bone formation 
when forcedly expressed in osteoprecursors[67]. Forced 
Hoxa2 expression in cells committed to undergo 
chondrogenesis also leads to chondrodysplasia and 
delayed cartilage mineralization and ossification, but 
does not affect proliferation of the chondrocytes[68]. 
Interestingly, Cbfa1 induction might inhibit Hoxa2 
caused impairment of osteogenic differentiation in 
vivo[67]. In addition, overexpression of HOXA2, and 
expression of HOXA3 and HOXB4, abolishes the ability 
of neural crest cells in the rostral domain to differentiate 
into skeletal structures in chicken[69]. The expression 
of certain Hox genes seems to inhibit skeletogenic 
differentiation, particularly jaw formation. In cranial 
neural crest cells there are specific regions where Hox 
expression or suppression, respectively is essential 
for appropriate development. In detail Hoxa2 inhibits 
Sox9, resulting in an impeded development of neural 
crest cells into ectomesenchymal stem cells and thus 
no osteochondral progenitors can form in mice. The 
absence of Hoxa2 leads to a migration of Sox9 into 
areas where Hoxa2 is normally expressed which induces 
ectopic chondrogenesis[70]. In addition, Hox genes 
suppress osteochondrogenesis in more posterior neural 
crest cells via epigenetic mechanisms[32]. Hoxa2 exerts 
an inhibitory effect in differentiation of chondrocytes, 
but is needed during bone formation. This effect is not 
related to the patterning function of Hoxa2, since it 
occurs in various tissues independent of their embryonic 
origin. Moreover, the ossification process itself is not 
affected by the Hoxa2 misexpression[68].
Hoxc8 as well as Hoxd4 regulate chondrogenesis 
in a dose dependent manner in mice. Hoxc8 does 
not block chondrogenesis, but alters the progression 
of chondrocytes and their differentiation pathway, 
leading to an accumulation of proliferating precursor 
cells, which negatively interfere with the progression 
of differentiation. A transgenic model for Hoxc8 and 
Hoxd4 signaling in chondrogenesis has been suggested, 
but the proposed effects have not yet been proven 
in in vitro culture systems with postnatal derived 
chondrocytes[71,72].
In Hoxa11 and Hoxd11 double mutant mice, cho-
ndrogenesis is initiated normally. Pre-chondrocytes 
express Sox9 and type Ⅱ collagen necessary for further 
differentiation. However, mesenchymal condensations, 
which later give rise to the radius and ulna, differ in 
shape and size from non-mutants[73]. Prehypertrophic 
cells within these condensations do no longer undergo 
their differentiation pathway towards hypertrophic 
chondrocytes. Hoxa11 and Hoxd11 double deficient 
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mice have shorter limb formation and development 
postnatal, together with delayed ossification, suggesting 
that these two Hox genes are important regulators in 
mammalian chondrogenesis[73]. This is in line with the 
finding that HOXA11 is expressed only in tissues which 
do not undergo chondrogenesis in chicken[74].
Also, Hox genes generate a positional memory 
in skeletal stem cells, influencing their differentiation 
potential. Murine skeletal progenitors derived from 
the mesoderm maintain Hoxa11 expression, whereas 
mandibular bone progenitors derived from the neural crest 
are negative for Hox expression. Thus an appropriate 
expression of Hox genes provides instructions for site-
specific differentiation and function of stem cells in vivo 
and in vitro[75]. 
Similar as already discussed for the adipogenic 
lineage commitment, the expression pattern of Hox genes 
in stem cell differentiations towards the osteogenic 
lineage varies according to the extraction site of 
the adipose tissue-derived stem cells. Hoxa4 and 
a5 expression is decreased in flank-derived MSCs 
differentiated towards osteoblasts, compared to the 
level in abdomen-derived stem cells, but Hoxa4 is 
dominantly expressed in arm-derived stem cells. Hoxc8 
and Hoxd4 on the other hand show a similar expression 
pattern in stem cells derived from the abdomen, arm, 
flank or thigh[76].
Genes within the D family of the Hox cluster are 
suggested to play a role in the condensation of MSCs 
and the further development into chondrocytes. In 
detail, HOXD9 and HOXD13 were found to be distinctly 
expressed in developing chondrocytes within MSCs 
from the chicken limb bud. The inhibition of HOXD10, 
D11, and D13, respectively, inhibits chondrogenesis[77]. 
This is in line with the finding that HOXD11 was found 
to act on initial cartilage condensation phases and later 
growth phases within the bone of chicken, whereas 
HOXD13 acts at later stages of bone development. 
Correspondingly, misexpression of HOXD13 is associated 
with a shortening of long bones[78]. This is supported by 
data derived from mice where Hoxd13 and to a lesser 
extent Hoxd12 were found to be essential for bone 
formation. A defect in one of these Hox genes leads to 
limb malformations and shorter bones[79]. Especially 
Hoxd13 seems to be responsible for the genetic switch 
from long bone to short bone formation[80]. But also 
Hoxd10 affects mouse limb development by impairing 
proper growth of skeletal elements[81]. Large fractures 
heal by processes very similar to bone formation during 
development, apart from remodeling and inflammatory 
responses[5].
The strict Hox gene pattering that could be observed 
in Drosophila melanogaster is even more complex 
during bone formation in vertebrae. In D. melanogaster 
genes closer to the DNA 5’-end are expressed strictly 
posterior and the more 3’ located Hox genes are 
strictly anterior. In agreement with that a knockout of 
Hoxd9 has revealed a more posterior impaired growth 
in the spine of mice than a knockout of Hoxd13[82]. 
  As already mentioned Hoxd13 is more essential 
for proper bone formation than Hoxd12, but defects 
in either of these Hox genes lead to a shortening of 
bones and limb malformations[79,81]. However, functions 
missing in knockout mice lacking a certain Hox gene 
may be compensated by other Hox genes. Hence, the 
severity when lacking either one of two Hox genes may 
be far less than if both Hox genes are knocked-out[82,83]. 
Cases where a Hox gene on both alleles is dysfunctional 
always show more severe bone malformations[79,81]. 
Also, stem cells from various sources show an origin-
specific Hox expression profile. Therefore, it is of great 
importance to match the Hox code of the cells subject 
to transplantation to the tissue of interest. It has been 
shown that USSCs, which are in vivo Hox negative and 
lack the potential to differentiate into the adipogenic 
lineage, gain this potency after these cells have been 
altered in their Hox expression profile in a co-culture 
model with CB-MSCs or bone marrow-derived stem 
cells. This however also affects the chondrogenic and 
osteogenic differentiation potential of USSCs[84]. The 
positional memory may hence be altered under the 
influence of Hox genes, but side effects have to be 
taken into consideration.
An indirect link between Hox expression and 
bone formation was examined recently. BMP4 (bone 
morphogenic protein) as well as BMP7 elevates the 
expression of KDM6B, which then causes a removal of 
H3K27me3 that normally inhibits Hox expression. Even 
though BMP is among other tasks directly responsible 
for bone formation this secondary function might 
further aid in the development[85].
A well understood example for how Hox genes 
are involved in bone formation is HOXA10. Again a 
BMP, here BMP2 induces HOXA10 which subsequently 
interacts directly with RUNX2, a main and early regulator 
of osteogenesis-specific gene expression[86,87]. This is 
supported by the finding of Gordon and colleagues[88] 
that Pbx1 is able to repress this Hoxa10-mediated 
osteogenic differentiation by blocking recruitment of 
chromatin remodeling factors and that overexpression of 
Hoxa10 increased the expression of osteoblast-related 
genes, osteoblast differentiation and mineralization[89].
Once bone and cartilage have been formed, they are 
connected to the musculature via tendons. Influencing 
the proper development and regeneration of tendons and 
striated muscle is therefore of great medical importance. 
However, little is known to date about the involvement 
of Hox genes in their developmental processes. The 
first and only data are about the autopodal Hox genes 
HOXA13 and HOXD13 inducing Six2 expression, which 
is a transcription factor present in developing tendon 
precursors, even in areas where it normally would not 
occur, such as the zeugopods of a chicken limb-bud[90]. 
Further investigations are therefore required to be able to 
improve overall limb regeneration with the help of stem 
cells under the influence of Hox genes.
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Hox expression in cardiovascular lineages
Regeneration and repair of the cardiovasculature is 
a major field of research in the scientific community, 
since it is the main cause of death with up to 50% 
in industrialized countries[91]. After transplantation of 
human bone marrow-derived stem cells into a murine 
adult heart, a limited number of cells survived and over 
time showed morphological and molecular changes, 
resembling the phenotype of host cardiomyocytes[92]. 
This has been reproduced in various studies and with 
a variety of donor tissues and hosts in vivo and in 
vitro[93,94]. Thus MSCs hence provide a valuable source for 
repairing injured myocardium in theory, but the underlying 
mechanism of differentiations towards myocytes and the 
cells of the blood vessels, e.g., endothelial and smooth 
muscle cells, has to be understood thoroughly to improve 
the outcome of such treatments. Knowing about changes 
in Hox gene expression in stem cell types and animal 
models may in the future help improve the differentiation 
of MSCs into cardiomyocytes for the transplantation into 
patients.
HOXA1 deficiency can cause cardiovascular diseases 
in mouse models as well as in human patients, which 
suggests its role in cardiomyocte differentiations[75,94-98]. 
TCDD can inhibit mouse embryonic stem cell differentiation 
towards cardiomyocytes. During this inhibition Hoxa10, 
a13, a7, Hoxb9, Hoxc8, c9, Hoxd1, d4, d9, d13 are 
upregulated, whereas Hoxb1 is down-regulated. In 
detail, Hoxb4 and Hoxd3 are upregulated with a lower 
dosage of 10 pmol/L TCDD and down-regulated at 
a dosage of 100 pmol/L TCDD. Hoxa9, Hoxb3, b8, 
Hoxc6 are down-regulated at a dosage of 10 pmol/L 
TCDD whereas upregulated at a dosage of 100 pmol/L 
TCDD[99]. In accordance to these findings, Hoxa10 has 
been found to impair murine cardiac differentiation in 
vivo[100].
In the vasculature, HOXA11 and A13 impact myogenic 
differentiation, as they repress MyoD expression and 
therefore initiation of myogenic differentiation in chicken 
limb muscle precursors transfected with these Hox 
genes[101]. Retention of Hox gene expression profiles 
and positional identity has been found in muscle cells 
and MSCs ex vivo[75,95-98].
The genes of the paralog groups Hox6-10 show 
a higher expression pattern in smooth muscle cells 
(SMCs) of the athero-resistant thoracic aorta compared 
to SMCs of the athero-susceptible aortic arch in mice, 
rat, and pork. This pattern is consistent in human 
ESCs which were differentiated into precursors of the 
thoracic aorta and the aortic arch, respectively, which 
also suggests a possible involvement of the above 
mentioned Hox genes in specific SMC differentiation 
processes of ESCs[102]. In vascular wall-resident 
multipotent stem cells (VW-MPSCs), HOXB7, HOXC6 
and C8 are expressed in high levels compared to 
human pluripotent ESCs, mature aortic smooth muscle 
cells and human umbilical cord endothelial cells[50]. 
Silencing of these Hox genes in VW-MPSCs leads to a 
reduction in their in-gel (Matrigel) sprouting capacity, 
hence suggesting a decreased differentiation potential 
without affecting proliferation[50]. Finally it has been 
found that in myogenic cells Hox gene expression is 
down-regulated via hypermethylation[103].
Changes in Hox gene expression over the differ-
entiation time course can also be observed in the stem 
cell differentiation towards endothelial cells. When mouse 
ESCs are differentiated towards endothelial cells, Hoxa3 
and Hoxd3, which drive angiogenesis and endothelial 
cell sprouting in adults, show a peak expression at day 
three of differentiation. Their expression declines over 
the following days of differentiation, whereas Hoxa5 and 
Hoxd10 arise from a low expression profile at day three 
of differentiation to a high expression profile over the 
course of time. In addition, these two Hox genes are 
involved in maintaining a mature quiescent endothelial 
cell phenotype[22]. This suggests an involvement of 
Hoxa5 and Hoxd10 in the differentiation of ESCs towards 
endothelial cells, whereas Hoxa3 and Hoxd3 rather 
mark an immature angiogenic endothelium and/or the 
onset of angiogenesis[22]. This has been confirmed by 
others who found that Hoxd10 suppresses angiogenesis, 
while Hoxd3 and Hoxb3 promote angiogenesis[104,105]. 
  Interestingly, the expression profile of Hox genes in 
human ESCs from leukemia prone infants is changed 
which might account for the impairment of hematopoietic 
cell differentiation in favor of endothelial cell fate. In 
these cells, HOXA9, A13, HOXB2, B3, B4, B5, and B6 
are strongly up-regulated[106]. Next to this, HOXA9 
is down-regulated in endothelial cells derived from 
endothelial progenitor cells from systemic sclerosis 
patients, suggesting an involvement of this Hox gene in 
endothelial cell differentiation or mal-differentiation[107].
During the differentiation of human bone marrow-
derived MSCs towards endothelial cells four Hox 
genes were found to be significantly altered in their 
expression profile. HOXA7 and HOXB3 expression is 
increased, whereas the expression of HOXA3 and 
HOXB13 ceased[108]. Also, HOXB5 up-regulates vascular 
endothelial growth factor receptor-2 which leads to an 
augmented endothelial cell precursor differentiation. 
Consequently, HOXB5 has also been proven to enhance 
endothelial cell sprouting and coordinated vascular 
growth in chicken[109]. A variety of Hox genes have 
already been found to influence call fate in favor of 
endothelial and smooth muscle cell lineages, but the 
exact mechanisms need to be made clearer in order 
to use them as transcription factors in regenerative 
therapies.
Hox expression in neurogenesis
Neurodegenerative diseases are also becoming more and 
more prominent within an aging population. Repairing the 
neurological systems within the body has been difficult 
ever since, due to its complexity. A detailed understanding 
of molecular processes involved in the development 
and differentiation of neuron precursors is of crucial 
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importance. Since Hox genes control the anterior-posterior 
(AP) segmentation, the 3’ genes in the Hox cluster are 
more prone to play a role in neurogenesis, and the 
paralog groups 1-4 have restricted expression borders in 
the hindbrain. The remaining paralog groups 5-13 reveal 
an anterior expression border in the spinal cord. This AP 
segmentation translates to the migration of neural crest 
cells[12].
In mouse models, Hoxb1 is essential for the correct 
development of rhombomeres at early embryonic stages, 
since it naturally induces neural stem cells towards a 
hindbrain identity, and has also been shown to be involved 
in the differentiation, maturation and maintenance of facial 
nerves[110,111]. Murine Hoxa2 and Hoxb1 can individually 
and as the sole additional factor induce motor neuron 
development, even in sections where they are usually 
not present[112]. In mice deficient for Hoxb1 expression, 
facial neurons do not properly form[113]. Also, HOXB4 
has been found to be a crucial factor in driving neuronal 
differentiations in the neural tube[114]. Further, since the 
disruption of Hoxa1 in mice leads to malformations of the 
hindbrain, a role for this Hox gene in murine neurogenesis 
has been suggested[115,116]. Retinoic acid (RA) has been 
established as an essential factor for adult neurogenesis. 
Embryonic stem cells treated with RA almost exclusively 
differentiate into neurons and develop a Hox expression 
profile[117]. Many Hox genes contain retinoic acid response 
elements (RAREs) which supports the finding that they 
are involved in RA-induced differentiation of ESCs[118]. 
RAREs have been found in Hoxa1, a4, Hoxb1, b4, and 
Hoxd4[12,119-128]. In fact, several Hox genes have been 
found to be strongly up-regulated in differentiations where 
RA was present[118]. The interaction between RA, Hox 
genes, and other signaling molecules has been visualized 
in Figure 2. During embryonic stem cell differentiation, 
highly conserved elements in the Hox gene clusters 
are epigenetically modified, so that adult spinal cord 
progenitors express a distinct Hox expression profile[129-131]. 
The further investigation of Hox genes in neurogenesis 
therefore promises a better insight into the possible 
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Table 2  Hox  genes play a role in various differentiations
Differentiation Hox  gene expression Ref.
Adipogenesis a4, a7, d4, A1, A4, A5, A10, B8, C4, C8 ↓, C13 [60-63]
Chondrogenesis a2 ↓, a11, c8 ↓, d4 ↓, d11, D9 ↑, D11, D13 ↑ [65,66,70-73,77,78]
Osteogenesis a2 ↑, a10, d9 ↓, d12, d13, A10 [82,86,87,89]
Tendon differentiation A13, D13 [90]
Cardiomyocyte differentiation a10, A1 [75,95-98,100]
Smooth muscle cell differentiation a6-10, b6-10, c6-10, d6-10, A11, A13, B7, C6, C8 [50,101,102]
Endothelial cell differentiation a3 ↓, a5 ↑, d3 ↓, d10 ↑, A7 ↑, A9 ↑, A13 ↑, B2 ↑, B3 ↑, B4 ↑, B5 ↑, B6 ↑, B13 ↑ [20,106-108]
Neurogenesis a2, b1, B4 [110-112,114-116]
Small capitals: Murine; Large capitals: Human and chicken; ↑: Up-regulation; ↓: Down-regulation.
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therapies to treat neurodegenerative diseases and should 
be pursued.
CONCLUSION
Degenerative diseases are one of the major problems 
arising within a population with high average age. The 
complex biological systems in the human body have 
made the development of regenerative therapies a 
challenging project. Much effort has been put into using 
stem cells and various signaling molecules for this 
purpose over the last decades. In this review, we have 
discussed the expression of Hox transcription factors in 
various types of stem cells and their role in differentiation. 
Interestingly already the stem cell source has an impact 
on the Hox gene expression in the respective stem cell 
type. Hox genes provide valuable possibilities to influence 
stem cell differentiations. Either single Hox genes or 
small groups have been found to directly influence the 
course of several differentiations, but detailed molecular 
changes under this influence are mostly not yet known. 
Additionally, many Hox genes have only revealed an 
indirect effect, or have been investigated in in vivo 
development but not in stem cell differentiations. Future 
studies need to be performed to investigate whether 
the suggested Hox genes, as summarized in Table 2 
for mesenchymal stem cell lineages, actually have a 
functional role in the in vitro differentiation of stem 
cells. Additionally, the effects must be tested in vivo to 
evaluate their therapeutic potential in tissue repair and 
regeneration[132]. As a consequence of the observed 
results it is suggested that cells which have their HOX 
code deleted regain plasticity and can be reprogrammed, 
similar as it has already been shown in iPS cells[133,134]. In 
addition to this and similar to iPS cells, also the epigenetic 
profile must be considered. We summarized that next 
to the histological compatibility of donor and host 
tissues the HOX code must be taken into consideration 
in regenerative therapies. In conclusion, the further 
investigation of Hox genes in stem cell differentiations is 
an interesting research field in regenerative medicine to 
improve tissue repair in injury, disease and aging. 
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